D&D Pharmatech, a South Korean biotechnology company, has raised a $137 million Series B round from a group of Korean and US investors.
US-based Octave Life Sciences co-led the funding round with Korea’s Smilegate Investment, while InterVest, Magna Investment, and LB Investment participated as well. All of the investors participated...
Mingyi Zhonghe, a software-as-a-service (SaaS) platform serving China’s rural clinics, has secured a RMB100 million ($14 million) Series B round led by Sinovation Ventures. Existing investor Yijing Capital re-upped.
Permira has reached a final close on its seventh global private equity buyout fund at the hard cap of EUR11 billion ($12.1 billion).
BGH Capital is looking to bring scale, capital and cross-selling opportunities to the still fragmented cybersecurity space in Australia and New Zealand
East Ventures and Sinar Mas Digital Ventures (SMDV) have co-led a $5.5 million Series A round for StickEarn, an Indonesian advertising technology supplier.